IRAK4-IN-32
IRAK4-IN-32 (Compound 10) is a potent interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor with an enzymatic IC50 value of 18.86 nM and a cellular IC50 value of 6.19 nM. IRAK4-IN-32 is promising for research of inflammatory and autoimmune diseases[1].
Product Specifications
UNSPSC
12352005
Target
IRAK
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CS(=O)(C1=CC=CC=C1NC2=NC(NC3=CC=C(N=C3)CO)=NC=C2Cl)=NC#N
Molecular Formula
C18H16ClN7O2S
Molecular Weight
429.88
References & Citations
[1]Kim K, et al. Synergistic optimizations of efficacy and membrane permeability of IRAK4 inhibitors: identifying new lead compounds for anti-inflammatory therapeutics. J Enzyme Inhib Med Chem. 2025 Dec;40 (1) :2518491.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IRAK4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC216045L4V 200 µL
Lenti ORF particles, TXNRD1 (mGFP-tagged) - Human thioredoxin reductase 1 (TXNRD1), transcript variant 3, (Note: selenocystein protein, Internal
Sign In for Pricing
View Details abx456266-01 50 µg
Ephrin RBD Domain-Containing Protein (EFNA4) Antibody
Sign In for Pricing
View Details abx456266-02 100 µg
Ephrin RBD Domain-Containing Protein (EFNA4) Antibody
Sign In for Pricing
View Details